Vertebral fractures cascade: potential causes and risk factors

被引:41
作者
Che, H. [1 ]
Breuil, V. [2 ]
Cortet, B. [3 ,4 ]
Paccou, J. [3 ,4 ]
Thomas, T. [5 ]
Chapuis, L. [6 ]
Debiais, F. [7 ]
Mehsen-Cetre, N. [8 ]
Javier, R. M. [9 ]
Peres, S. Loiseau [10 ]
Roux, C. [11 ]
Briot, K. [11 ]
机构
[1] CHU Lapeyronie Montpellier, Rheumatol Dept, 371 Ave Gaston Giraud, F-34090 Montpellier, France
[2] Univ Cote DAzur, CHU Nice, Dept Rheumatol, BIAM,TIRO,MATOs,CEA,UNS,UMR E 4320, Nice, France
[3] Univ Littoral Cote dOpale, CHRU France, Serv Rhumatol, Fac Chirurg Dentaire,PMOI EA 4490, Pl Verdun, F-59000 Lille, France
[4] Univ Littoral Cote dOpale, Univ Lille, PMOI EA 4490, Fac Chirurg Dentaire, Pl Verdun, F-59000 Lille, France
[5] Univ Lyon, CHU St Etienne, Lab Biol Integree Tissu Osseux, Rheumatol Dept,INSERM,U1059, F-42055 St Etienne 2, France
[6] CH Simone Veil Vitre, Rheumatol Dept, 30 Route Rennes, F-35500 Vitre, France
[7] CHU La Miletrie Poitiers, Rheumatol Dept, 2 Rue Miletrie, F-86021 Poitiers, France
[8] CHU Pellegrin Bordeaux, Rheumatol Dept, Rue Pelouse Douet, F-33000 Bordeaux, France
[9] Hop Univ Strasbourg, Rheumatol Dept, 1 Ave Moliere, F-67098 Strasbourg, France
[10] CHR Orleans, Rheumatol Dept, 14 Ave Hop, F-45000 Orleans, France
[11] Paris Descartes Univ, CHU Paris Cochin, INSERM 1153, Rheumatol Dept, 27 Rue Faubourg St Jacques, F-75014 Paris, France
关键词
Cascade; Osteoporosis; Risks factors; Vertebral fractures; DENOSUMAB DISCONTINUATION; COMPRESSION FRACTURES; RANDOMIZED-TRIAL; OLDER WOMEN; OSTEOPOROSIS; VERTEBROPLASTY; PREVALENT; MASTOCYTOSIS; DEFORMITIES; MORTALITY;
D O I
10.1007/s00198-018-4793-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We performed a study to identify potential causes and risk factors of vertebral fracture cascade. Vertebral fracture cascade is a severe clinical event in patients with bone fragility. Only half of patients have an identified cause of secondary osteoporosis.IntroductionVertebral fracture (VF) is the most common osteoporotic fracture, and a strong risk factor of subsequent VFs leading to VF cascade (VFC). We prompted a study to identify potential causes and risk factors of VFC.MethodsVFC observations were collected retrospectively between January 2016 and April 2017. VFC was defined as an occurrence of at least three VFs within 1year.ResultsWe included in 10 centers a total of 113 patients with VFC (79.6% of women, median age 73, median number of VFs in the cascade, 5). We observed 40.5% and 30.9% of patients with previous major fractures and a previous VF, respectively, and 68.6% with densitometric osteoporosis; 18.9% of patients were currently receiving oral glucocorticoids and 37.1% in the past.VFC was attributed by the physician to postmenopausal osteoporosis in 54% of patients. A secondary osteoporosis associated with the VFC was diagnosed in 52 patients: glucocorticoid-induced osteoporosis (25.7%), non-malignant hemopathies (6.2%), alcoholism (4.4%), use of aromatase inhibitors (3.6%), primary hyperparathyroidism (2.7%), hypercorticism (2.7%), anorexia nervosa (2.7%), and pregnancy and lactation-associated osteoporosis (1.8%). A total of 11.8% of cases were reported following a vertebroplasty procedure. A total of 31.5% patients previously received an anti-osteoporotic treatment. In six patients, VFC occurred early after discontinuation of an anti-osteoporotic treatment, in the year after the last dose effect was depleted: five after denosumab and one after odanacatib.ConclusionThe results of this retrospective study showed that only half of VFC occurred in patients with a secondary cause of osteoporosis. Prospective studies are needed to further explore the determinants of this severe complication of osteoporosis.
引用
收藏
页码:555 / 563
页数:9
相关论文
共 45 条
[1]   Efficacy and tolerance of vertebroplasty and kyphoplasty for vertebral osteoporotic fractures at Lille University Hospital [J].
Abbad, Noemie ;
Lemeunier, Lucie ;
Cotten, Anne ;
Chastanet, Patrick ;
Cortet, Bernard .
PRESSE MEDICALE, 2016, 45 (05) :552-555
[2]  
Abramowitz Jessica D, 2012, Endocr Pract, V18, pe158, DOI 10.4158/EP12062.CR
[3]   Fracture risk in oral glucocorticoid users: a Bayesian meta-regression leveraging control arms of osteoporosis clinical trials [J].
Amiche, M. A. ;
Albaum, J. M. ;
Tadrous, M. ;
Pechlivanoglou, P. ;
Levesque, L. E. ;
Adachi, J. D. ;
Cadarette, S. M. .
OSTEOPOROSIS INTERNATIONAL, 2016, 27 (05) :1709-1718
[4]   Multiple Vertebral Fractures Following Denosumab Discontinuation: Are We Exaggerating? [J].
Anastasilakis, Athanasios D. ;
Tournis, Symeon ;
Yavropoulou, Maria P. ;
Polyzos, Stergios A. ;
Makras, Polyzois .
CALCIFIED TISSUE INTERNATIONAL, 2018, 103 (01) :107-108
[5]   Clinical Features of 24 Patients With Rebound-Associated Vertebral Fractures After Denosumab Discontinuation: Systematic Review and Additional Cases [J].
Anastasilakis, Athanasios D. ;
Polyzos, Stergios A. ;
Makras, Polyzois ;
Aubry-Rozier, Berengere ;
Kaouri, Stella ;
Lamy, Olivier .
JOURNAL OF BONE AND MINERAL RESEARCH, 2017, 32 (06) :1291-1296
[6]   Increased osteoclastogenesis in patients with vertebral fractures following discontinuation of denosumab treatment [J].
Anastasilakis, Athanasios D. ;
Yavropoulou, Maria P. ;
Makras, Polyzois ;
Sakellariou, Grigorios T. ;
Papadopoulou, Fotini ;
Gerou, Spyridon ;
Papapoulos, Socrates E. .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2017, 176 (06) :677-683
[7]   SKELETAL MASTOCYTOSIS [J].
ANDREW, SM ;
FREEMONT, AJ .
JOURNAL OF CLINICAL PATHOLOGY, 1993, 46 (11) :1033-1035
[8]   Severe spontaneous vertebral fractures after denosumab discontinuation: three case reports [J].
Aubry-Rozier, B. ;
Gonzalez-Rodriguez, E. ;
Stoll, D. ;
Lamy, O. .
OSTEOPOROSIS INTERNATIONAL, 2016, 27 (05) :1923-1925
[9]   Systemic mastocytosis and bone involvement in a cohort of 75 patients [J].
Barete, S. ;
Assous, N. ;
de Gennes, C. ;
Grandpeix, C. ;
Feger, F. ;
Palmerini, F. ;
Dubreuil, P. ;
Arock, M. ;
Roux, C. ;
Launay, J. M. ;
Fraitag, S. ;
Canioni, D. ;
Billemont, B. ;
Suarez, F. ;
Lanternier, F. ;
Lortholary, O. ;
Hermine, O. ;
Frances, C. .
ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (10) :1838-1841
[10]   Multiple vertebral fractures following osteoporosis treatment discontinuation: a case-report after long-term Odanacatib [J].
Binkley, N. ;
Krueger, D. ;
de Papp, A. E. .
OSTEOPOROSIS INTERNATIONAL, 2018, 29 (04) :999-1002